25696-60-0 (2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-三羟基-10,13-二甲基-2,3,4,5,6,7,8,9,11,12,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基]戊酰]氨基]乙烷磺酸,Ethanesulfonic acid,2-[[(3a,5b,6b,7b)-3,6,7-trihydroxy-24-oxocholan-24-yl]amino]-)

CAS号:
25696-60-0
中文名称:
2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-三羟基-10,13-二甲基-2,3,4,5,6,7,8,9,11,12,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基]戊酰]氨基]乙烷磺酸
英文名称:
Ethanesulfonic acid,2-[[(3a,5b,6b,7b)-3,6,7-trihydroxy-24-oxocholan-24-yl]amino]-
分子式:
C26H45NO7S
分子量:
515.703007459641

2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-三羟基-10,13-二甲基-2,3,4,5,6,7,8,9,11,12,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基]戊酰]氨基]乙烷磺酸(25696-60-0)名称与标识符

名称

中文别名:
2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-三羟基-10,13-二甲基-2,3,4,5,6,7,8,9,11,12,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基]戊酰]氨基]乙烷磺酸;
英文别名:
Ethanesulfonic acid,2-[[(3a,5b,6b,7b)-3,6,7-trihydroxy-24-oxocholan-24-yl]amino]-;Tauro-β-muricholic Acid;Tauro-β-muricholic A;tauroβ-muricholic acid;Cholane, ethanesulfonic acid deriv.;Taurine,N-(3a,6b,7b-trihydroxy-5b-cholan-24-oyl)- (8CI);Tauro-b-muricholate;Tauro-b-muricholic acid;N-(3a,6b,7b-trihydroxy-5b-cholan-24-oyl)-Taurine;T-alpha-MC;DTXSID80948572;Ethanesulfonic acid, 2-(((3alpha,5beta,6beta,7beta)-3,6,7-trihydroxy-24-oxocholan-24-yl)amino)-;2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid;Tauromuricholic acid;tauro-beta-muricholic acid;SCHEMBL21712539;3,6,7-Trihydroxy-N-(2-sulfoethyl)cholan-24-imidic acid;Tauro-alpha-muricholate;25696-60-0;Tauro-alpha-muricholic acid;NS00126721;DB-226978;

标识符

MDL:
MFCD01310715
InChIKey:
XSOLDPYUICCHJX-ZWEIDOTMSA-N
Inchi:
1S/C26H45NO7S/c1-15(4-7-21(29)27-12-13-35(32,33)34)17-5-6-18-22-19(9-11-25(17,18)2)26(3)10-8-16(28)14-20(26)23(30)24(22)31/h15-20,22-24,28,30-31H,4-14H2,1-3H3,(H,27,29)(H,32,33,34)/t15-,16-,17-,18?,19?,20+,22?,23+,24?,25-,26-/m1/s1
SMILES:
S(CCNC(CC[C@@H](C)[C@H]1CCC2[C@]1(C)CCC1[C@@]3(C)CC[C@H](C[C@H]3[C@@H](C(C21)O)O)O)=O)(=O)(=O)O

2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-三羟基-10,13-二甲基-2,3,4,5,6,7,8,9,11,12,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基]戊酰]氨基]乙烷磺酸(25696-60-0)物化性质

实验特性

  • PSA : 144.16

计算特性

  • 精确分子量 : 515.29185
  • 氢键供体数量 : 5
  • 氢键受体数量 : 7
  • 可旋转化学键数量 : 7
  • 同位素质量 : 515.29167395g/mol
  • 重原子数量 : 35
  • 复杂度 : 891
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 8
  • 不确定原子立构中心数量 : 3
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2.6
  • 拓扑分子极性表面积 : 153Ų

2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-三羟基-10,13-二甲基-2,3,4,5,6,7,8,9,11,12,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基]戊酰]氨基]乙烷磺酸(25696-60-0)推荐厂家 更多厂家(11)

2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-三羟基-10,13-二甲基-2,3,4,5,6,7,8,9,11,12,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基]戊酰]氨基]乙烷磺酸(25696-60-0)相关文献